545 related articles for article (PubMed ID: 21664078)
1. Efficacy of a pandemic (H1N1) 2009 virus vaccine in pigs against the pandemic influenza virus is superior to commercially available swine influenza vaccines.
Loeffen WL; Stockhofe N; Weesendorp E; van Zoelen-Bos D; Heutink R; Quak S; Goovaerts D; Heldens JG; Maas R; Moormann RJ; Koch G
Vet Microbiol; 2011 Sep; 152(3-4):304-14. PubMed ID: 21664078
[TBL] [Abstract][Full Text] [Related]
2. Protective efficacy of a high-growth reassortant H1N1 influenza virus vaccine against the European Avian-like H1N1 swine influenza virus in mice and pigs.
Ruan BY; Wen F; Gong XQ; Liu XM; Wang Q; Yu LX; Wang SY; Zhang P; Yang HM; Shan TL; Zheng H; Zhou YJ; Tong W; Gao F; Tong GZ; Yu H
Vet Microbiol; 2018 Aug; 222():75-84. PubMed ID: 30080677
[TBL] [Abstract][Full Text] [Related]
3. Reassortant H1N1 influenza virus vaccines protect pigs against pandemic H1N1 influenza virus and H1N2 swine influenza virus challenge.
Yang H; Chen Y; Shi J; Guo J; Xin X; Zhang J; Wang D; Shu Y; Qiao C; Chen H
Vet Microbiol; 2011 Sep; 152(3-4):229-34. PubMed ID: 21596495
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of a high-growth reassortant H1N1 influenza virus vaccine against the classical swine H1N1 subtype influenza virus in mice and pigs.
Wen F; Yu H; Yang FR; Huang M; Yang S; Zhou YJ; Li ZJ; Tong GZ
Arch Virol; 2014 Nov; 159(11):2957-67. PubMed ID: 24957653
[TBL] [Abstract][Full Text] [Related]
5. Vaccination with a soluble recombinant hemagglutinin trimer protects pigs against a challenge with pandemic (H1N1) 2009 influenza virus.
Loeffen WL; de Vries RP; Stockhofe N; van Zoelen-Bos D; Maas R; Koch G; Moormann RJ; Rottier PJ; de Haan CA
Vaccine; 2011 Feb; 29(8):1545-50. PubMed ID: 21219983
[TBL] [Abstract][Full Text] [Related]
6. Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine.
Richt JA; Lekcharoensuk P; Lager KM; Vincent AL; Loiacono CM; Janke BH; Wu WH; Yoon KJ; Webby RJ; Solórzano A; García-Sastre A
J Virol; 2006 Nov; 80(22):11009-18. PubMed ID: 16943300
[TBL] [Abstract][Full Text] [Related]
7. A polyvalent influenza A DNA vaccine induces heterologous immunity and protects pigs against pandemic A(H1N1)pdm09 virus infection.
Bragstad K; Vinner L; Hansen MS; Nielsen J; Fomsgaard A
Vaccine; 2013 Apr; 31(18):2281-8. PubMed ID: 23499598
[TBL] [Abstract][Full Text] [Related]
8. Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses.
Pena L; Vincent AL; Ye J; Ciacci-Zanella JR; Angel M; Lorusso A; Gauger PC; Janke BH; Loving CL; Perez DR
J Virol; 2011 Jan; 85(1):456-69. PubMed ID: 20962084
[TBL] [Abstract][Full Text] [Related]
9. Protection of pigs against pandemic swine origin H1N1 influenza A virus infection by hemagglutinin- or neuraminidase-expressing attenuated pseudorabies virus recombinants.
Klingbeil K; Lange E; Blohm U; Teifke JP; Mettenleiter TC; Fuchs W
Virus Res; 2015 Mar; 199():20-30. PubMed ID: 25599604
[TBL] [Abstract][Full Text] [Related]
10. Protection of human influenza vaccines against a reassortant swine influenza virus of pandemic H1N1 origin using a pig model.
Arunorat J; Charoenvisal N; Woonwong Y; Kedkovid R; Jittimanee S; Sitthicharoenchai P; Kesdangsakonwut S; Poolperm P; Thanawongnuwech R
Res Vet Sci; 2017 Oct; 114():6-11. PubMed ID: 28267619
[TBL] [Abstract][Full Text] [Related]
11. Efficacy in pigs of inactivated and live attenuated influenza virus vaccines against infection and transmission of an emerging H3N2 similar to the 2011-2012 H3N2v.
Loving CL; Lager KM; Vincent AL; Brockmeier SL; Gauger PC; Anderson TK; Kitikoon P; Perez DR; Kehrli ME
J Virol; 2013 Sep; 87(17):9895-903. PubMed ID: 23824815
[TBL] [Abstract][Full Text] [Related]
12. [Swine influenza virus: evolution mechanism and epidemic characterization--a review].
Qi X; Lu C
Wei Sheng Wu Xue Bao; 2009 Sep; 49(9):1138-45. PubMed ID: 20030049
[TBL] [Abstract][Full Text] [Related]
13. Protective efficacy of a bivalent inactivated reassortant H1N1 influenza virus vaccine against European avian-like and classical swine influenza H1N1 viruses in mice.
Ruan BY; Yao Y; Wang SY; Gong XQ; Liu XM; Wang Q; Yu LX; Zhu SQ; Wang J; Shan TL; Zhou YJ; Tong W; Zheng H; Li GX; Gao F; Kong N; Yu H; Tong GZ
Vet Microbiol; 2020 Jul; 246():108724. PubMed ID: 32605742
[TBL] [Abstract][Full Text] [Related]
14. Investigations of the efficacy of European H1N1- and H3N2-based swine influenza vaccines against the novel H1N2 subtype.
Van Reeth K; Van Gucht S; Pensaert M
Vet Rec; 2003 Jul; 153(1):9-13. PubMed ID: 12877210
[TBL] [Abstract][Full Text] [Related]
15. Age at Vaccination and Timing of Infection Do Not Alter Vaccine-Associated Enhanced Respiratory Disease in Influenza A Virus-Infected Pigs.
Souza CK; Rajão DS; Loving CL; Gauger PC; Pérez DR; Vincent AL
Clin Vaccine Immunol; 2016 Jun; 23(6):470-482. PubMed ID: 27030585
[TBL] [Abstract][Full Text] [Related]
16. Swine influenza virus vaccine serologic cross-reactivity to contemporary US swine H3N2 and efficacy in pigs infected with an H3N2 similar to 2011-2012 H3N2v.
Kitikoon P; Gauger PC; Anderson TK; Culhane MR; Swenson S; Loving CL; Perez DR; Vincent AL
Influenza Other Respir Viruses; 2013 Dec; 7 Suppl 4(Suppl 4):32-41. PubMed ID: 24224818
[TBL] [Abstract][Full Text] [Related]
17. Protection of guinea pigs by vaccination with a recombinant swinepox virus co-expressing HA1 genes of swine H1N1 and H3N2 influenza viruses.
Xu J; Yang D; Huang D; Xu J; Liu S; Lin H; Zhu H; Liu B; Lu C
Arch Virol; 2013 Mar; 158(3):629-37. PubMed ID: 23135159
[TBL] [Abstract][Full Text] [Related]
18. DNA vaccine based on conserved HA-peptides induces strong immune response and rapidly clears influenza virus infection from vaccinated pigs.
Sisteré-Oró M; López-Serrano S; Veljkovic V; Pina-Pedrero S; Vergara-Alert J; Córdoba L; Pérez-Maillo M; Pleguezuelos P; Vidal E; Segalés J; Nielsen J; Fomsgaard A; Darji A
PLoS One; 2019; 14(9):e0222201. PubMed ID: 31553755
[TBL] [Abstract][Full Text] [Related]
19. Vaccine-associated enhanced respiratory disease is influenced by haemagglutinin and neuraminidase in whole inactivated influenza virus vaccines.
Rajão DS; Chen H; Perez DR; Sandbulte MR; Gauger PC; Loving CL; Shanks GD; Vincent A
J Gen Virol; 2016 Jul; 97(7):1489-1499. PubMed ID: 27031847
[TBL] [Abstract][Full Text] [Related]
20. Vaccination decreases the risk of influenza A virus reassortment but not genetic variation in pigs.
Li C; Culhane MR; Schroeder DC; Cheeran MC; Galina Pantoja L; Jansen ML; Torremorell M
Elife; 2022 Sep; 11():. PubMed ID: 36052992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
